{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T07:51:24Z","timestamp":1773733884022,"version":"3.50.1"},"reference-count":181,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.cca.2005.10.017","type":"journal-article","created":{"date-parts":[[2005,12,8]],"date-time":"2005-12-08T12:14:25Z","timestamp":1134044065000},"page":"14-26","source":"Crossref","is-referenced-by-count":34,"title":["Genomic variants in polycystic ovary syndrome"],"prefix":"10.1016","volume":"366","author":[{"given":"Manuel","family":"Luque-Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"San Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor F.","family":"Escobar-Morreale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2005.10.017_bib1","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2005.10.017_bib2","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/er.18.6.774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cca.2005.10.017_bib3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0002-9378(15)33704-2","article-title":"Hereditary factors in the Stein-Leventhal syndrome","volume":"100","author":"Cooper","year":"1968","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cca.2005.10.017_bib4","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0889-8529(18)30409-2","article-title":"Familial polycystic ovarian disease","volume":"17","author":"Givens","year":"1988","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.cca.2005.10.017_bib5","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1210\/jc.87.5.2128","article-title":"Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity","volume":"87","author":"Legro","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib6","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1210\/jc.2002-021499","article-title":"Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome","volume":"88","author":"Yildiz","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2265.2004.01981.x","article-title":"Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries","volume":"60","author":"Kaushal","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cca.2005.10.017_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/er.2004-0004","article-title":"The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome","volume":"26","author":"Escobar-Morreale","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cca.2005.10.017_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00041433-200302000-00009","article-title":"Cardiovascular disease genetics: a long and winding road","volume":"14","author":"Ordovas","year":"2003","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cca.2005.10.017_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7326\/0003-4819-139-5_Part_2-200309021-00011","article-title":"Gene-environment interactions and the etiology of common complex disease","volume":"139","author":"Cooper","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cca.2005.10.017_bib11","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1016\/S0002-9343(98)00184-3","article-title":"Biologic markers as predictors of cardiovascular disease","volume":"104","author":"Frishman","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.cca.2005.10.017_bib12","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1210\/er.2002-0010","article-title":"Insulin resistance and chronic cardiovascular inflammatory syndrome","volume":"24","author":"Fernandez-Real","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cca.2005.10.017_bib13","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jc.86.6.2453","article-title":"Low grade chronic inflammation in women with polycystic ovarian syndrome","volume":"86","author":"Kelly","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib14","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1210\/jc.2003-031096","article-title":"Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease","volume":"89","author":"Boulman","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib15","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1210\/jc.85.9.3338","article-title":"Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss","volume":"85","author":"Bastard","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib16","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1210\/jc.86.8.3761","article-title":"TNF-\u03b1 and hyperandrogenism: a clinical, biochemical and molecular genetic study","volume":"86","author":"Escobar-Morreale","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib17","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1210\/jc.87.3.1134","article-title":"The \u2212597 G\/A and \u2212174 G\/C polymorphisms in the promoter of the interleukin 6 gene (IL6) are associated with hyperandrogenism","volume":"87","author":"Villuendas","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib18","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1210\/jc.87.8.3977","article-title":"The methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism","volume":"87","author":"Peral","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib19","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/oby.2003.136","article-title":"Association of polymorphisms in the Interleukin 6 receptor complex with obesity and hyperandrogenism","volume":"11","author":"Escobar-Morreale","year":"2003","journal-title":"Obes Res"},{"key":"10.1016\/j.cca.2005.10.017_bib20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00125-003-1090-z","article-title":"Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women","volume":"46","author":"Escobar-Morreale","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2005.10.017_bib21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1530\/eje.0.1500525","article-title":"The polycystic ovary syndrome per se is not associated with increased chronic inflammation","volume":"150","author":"Mohlig","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cca.2005.10.017_bib22","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(97)06062-5","article-title":"Fetal growth, length of gestation, and polycystic ovaries in adult life","volume":"350","author":"Cresswell","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2005.10.017_bib23","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","article-title":"Obesity and the polycystic ovary syndrome","volume":"26","author":"Gambineri","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.cca.2005.10.017_bib24","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/0002-9378(92)91779-A","article-title":"Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?","volume":"167","author":"Carmina","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cca.2005.10.017_bib25","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1210\/jc.2003-030666","article-title":"Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome","volume":"89","author":"Kasim-Karakas","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib26","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1210\/jc.85.7.2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asunci\u00f3n","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib27","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib28","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jc.84.11.4006","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib29","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s001250051451","article-title":"Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype\/phenotype to thriftiness","volume":"42","author":"Fernandez-Real","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2005.10.017_bib30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1056\/NEJM198501313120505","article-title":"Paleolithic nutrition. A consideration of its nature and current implications","volume":"312","author":"Eaton","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2005.10.017_bib31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1025619510292","article-title":"Success in mating: a coordinated approach to fitness through genotypes incorporating genes for stress resistance and heterozygous advantage under stress","volume":"27","author":"Parsons","year":"1997","journal-title":"Behav Genet"},{"key":"10.1016\/j.cca.2005.10.017_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/jcem-50-1-113","article-title":"Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease","volume":"50","author":"Burghen","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib33","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0002-9378(83)90023-6","article-title":"Insulin resistance in polycystic ovary syndrome","volume":"147","author":"Shoupe","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cca.2005.10.017_bib34","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-57-2-356","article-title":"Insulin resistance in nonobese patients with polycystic ovarian disease","volume":"57","author":"Chang","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib35","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diabetes.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2005.10.017_bib36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0015-0282(16)56633-3","article-title":"Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia","volume":"61","author":"Rajkhowa","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cca.2005.10.017_bib37","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/endo-108-4-1441","article-title":"Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells","volume":"108","author":"Adashi","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2005.10.017_bib38","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1210\/jc.81.3.881","article-title":"Insulin infusion amplifies 17-alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women\u2014apparent relative impairment of 17,20-lyase activity","volume":"81","author":"Moghetti","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.20.4.535","article-title":"The insulin-related ovarian regulatory system in health and disease","volume":"20","author":"Poretsky","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cca.2005.10.017_bib40","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome","volume":"335","author":"Nestler","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2005.10.017_bib41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.76.2.273","article-title":"Sex hormone-binding globulin: a marker for hyperinsulinemia and\/or insulin resistance?","volume":"76","author":"Nestler","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2007-1016294","article-title":"Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications","volume":"15","author":"Nestler","year":"1997","journal-title":"Semin Reprod Endocrinol"},{"key":"10.1016\/j.cca.2005.10.017_bib43","first-page":"81","article-title":"Hyperthecosis: an inheritable form of polycystic ovarian disease","volume":"11","author":"Wilroy","year":"1975","journal-title":"Birth Defects Orig Artic Ser"},{"key":"10.1016\/j.cca.2005.10.017_bib44","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM197109162851221","article-title":"Ovarian hyperthecosis","volume":"285","author":"Givens","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2005.10.017_bib45","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1210\/jc.2004-2217","article-title":"Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome","volume":"90","author":"Sam","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib46","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1172\/JCI118064","article-title":"Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus","volume":"96","author":"Ehrmann","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2005.10.017_bib47","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.86.5.2027","article-title":"Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives","volume":"86","author":"Colilla","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib48","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/ng0793-305","article-title":"Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR","volume":"4","author":"Lucassen","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.cca.2005.10.017_bib49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/295031a0","article-title":"The highly polymorphic region near the human insulin gene is composed of simple tandemly repeating sequences","volume":"295","author":"Bell","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.cca.2005.10.017_bib50","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(96)08368-7","article-title":"Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome","volume":"349","author":"Waterworth","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2005.10.017_bib51","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2265.2001.01375.x","article-title":"Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight","volume":"55","author":"Michelmore","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cca.2005.10.017_bib52","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0015-0282(01)03238-1","article-title":"Insulin gene variable number of tandem repeats regulatory polymorphism is not associated with hyperandrogenism in Spanish women","volume":"77","author":"Calvo","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cca.2005.10.017_bib53","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1749-6632.2002.tb04317.x","article-title":"Association of insulin gene VNTR polymorphism with polycystic ovary syndrome","volume":"967","author":"Vankova","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2005.10.017_bib54","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1210\/jc.2004-2485","article-title":"Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits","volume":"90","author":"Powell","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib55","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1172\/JCI118126","article-title":"Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome","volume":"96","author":"Dunaif","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2005.10.017_bib56","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1210\/jc.2002-020363","article-title":"Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators","volume":"87","author":"Li","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib57","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/oxfordjournals.humrep.a138773","article-title":"The tyrosine kinase domain of the insulin receptor gene is normal in women with hyperinsulinaemia and polycystic ovary syndrome","volume":"9","author":"Conway","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cca.2005.10.017_bib58","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0015-0282(02)04241-3","article-title":"A C\/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome","volume":"78","author":"Siegel","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cca.2005.10.017_bib59","first-page":"582","article-title":"Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome","volume":"39","author":"Chen","year":"2004","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.1016\/j.cca.2005.10.017_bib60","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.96.15.8573","article-title":"Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin","volume":"96","author":"Urbanek","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2005.10.017_bib61","doi-asserted-by":"crossref","unstructured":"M. Urbanek, A. Woodroffe, K.G., Ewens, et al. Candidate gene region for polycystic ovary syndrome (PCOS) on chromosome 19p13.2. J Clin Endocrinol Metab 2005 [First published August 9 as doi:10.1210\/jc.2005\u20130622].","DOI":"10.1210\/jc.2005-0622"},{"key":"10.1016\/j.cca.2005.10.017_bib62","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1210\/jc.86.1.446","article-title":"Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus","volume":"86","author":"Tucci","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0015-0282(02)04570-3","article-title":"Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome","volume":"79","author":"Villuendas","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cca.2005.10.017_bib64","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/0026-0495(94)90018-3","article-title":"Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome","volume":"43","author":"Sorbara","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2005.10.017_bib65","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1210\/jc.81.5.1979","article-title":"Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome","volume":"81","author":"Talbot","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib66","series-title":"Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling","first-page":"E1047","volume":"288","author":"Corbould","year":"2005"},{"key":"10.1016\/j.cca.2005.10.017_bib67","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1007\/s001250170001","article-title":"G972R polymorphism of IRS-1 in women with polycystic ovary syndrome","volume":"44","author":"Sir-Petermann","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2005.10.017_bib68","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.2337\/diabetes.50.9.2164","article-title":"Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome","volume":"50","author":"El Mkadem","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2005.10.017_bib69","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1210\/jc.2002-020216","article-title":"Relationship of insulin receptor substrate-1 and-2 genotypes to phenotypic features of polycystic ovary syndrome","volume":"87","author":"Ehrmann","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib70","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1093\/humrep\/dei205","article-title":"Polymorphisms in the insulin receptor substrate-1 (IRS-1) gene and the insulin receptor substrate-2 (IRS-2) gene influence glucose homeostasis and body mass index in women with polycystic ovary syndrome and non-hyperandrogenic controls","volume":"20","author":"Villuendas","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cca.2005.10.017_bib71","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/jc.2003-031252","article-title":"Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity","volume":"89","author":"San Millan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib72","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0015-0282(01)01982-3","article-title":"Inconsistent effects of the proline12->alanine variant of the peroxisome proliferator-activated receptor-gamma2 gene on body mass index in children and adolescent girls","volume":"76","author":"Witchel","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cca.2005.10.017_bib73","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1210\/jc.87.2.772","article-title":"Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene","volume":"87","author":"Hara","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib74","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/humrep\/deg128","article-title":"Polymorphism in the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome","volume":"18","author":"Korhonen","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cca.2005.10.017_bib75","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/humrep\/deh769","article-title":"Evaluation of glucose metabolism and reproductive hormones in polycystic ovary syndrome on the basis of peroxisome proliferator-activated receptor (PPAR)-gamma2 Pro12Ala genotype","volume":"20","author":"Tok","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cca.2005.10.017_bib76","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2265.2005.02261.x","article-title":"The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome","volume":"62","author":"Hahn","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cca.2005.10.017_bib77","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1210\/jc.87.4.1669","article-title":"Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome","volume":"87","author":"Ehrmann","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib78","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0015-0282(01)03206-X","article-title":"Common single nucleotide polymorphisms in intron 3 of the calpain-10 gene influence hirsutism","volume":"77","author":"Escobar-Morreale","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cca.2005.10.017_bib79","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1210\/jc.87.8.3971","article-title":"Comment: CAPN10 alleles are associated with polycystic ovary syndrome","volume":"87","author":"Gonzalez","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib80","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1210\/jc.2003-030322","article-title":"Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients","volume":"88","author":"Gonzalez","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib81","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1093\/humrep\/deh336","article-title":"Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of Delta4-androstenedione","volume":"19","author":"Panidis","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cca.2005.10.017_bib82","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1373\/clinchem.2004.043109","article-title":"Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome","volume":"51","author":"Xita","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2005.10.017_bib83","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1210\/jc.2002-021816","article-title":"Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome","volume":"88","author":"Orio","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib84","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1210\/jc.2004-0109","article-title":"Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome","volume":"89","author":"Orio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib85","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0015-0282(03)00506-5","article-title":"Frequency of the T228A polymorphism in the SORBS1 gene in children with premature pubarche and in adolescent girls with hyperandrogenism","volume":"80","author":"Witchel","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cca.2005.10.017_bib86","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1210\/jc.87.6.2606","article-title":"Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome","volume":"87","author":"Haddad","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib87","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2265.2005.02256.x","article-title":"Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS)","volume":"62","author":"Kumar","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cca.2005.10.017_bib88","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2265.1993.tb02150.x","article-title":"Evidence for a single gene effect causing polycystic ovaries and male pattern baldness","volume":"38","author":"Carey","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cca.2005.10.017_bib89","doi-asserted-by":"crossref","first-page":"287","DOI":"10.33549\/physiolres.930573","article-title":"What may be the markers of the male equivalent of polycystic ovary syndrome?","volume":"53","author":"Duskova","year":"2004","journal-title":"Physiol Res"},{"key":"10.1016\/j.cca.2005.10.017_bib90","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1210\/jc.87.5.2134","article-title":"Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome","volume":"87","author":"Legro","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib91","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.16.3.322","article-title":"Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion","volume":"16","author":"Ehrmann","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cca.2005.10.017_bib92","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1210\/jc.80.4.1257","article-title":"Occurrence and biological properties of a common genetic variant of luteinizing hormone","volume":"80","author":"Haavisto","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib93","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1210\/jc.84.5.1711","article-title":"A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone","volume":"84","author":"Tapanainen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib94","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0015-0282(98)00491-9","article-title":"Role of the mutations Trp8=>Arg and Ile15=>Thr of the human luteinizing hormone beta-subunit in women with polycystic ovary syndrome","volume":"71","author":"Elter","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cca.2005.10.017_bib95","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/sj.ejhg.5200968","article-title":"Influence of missense mutation and silent mutation of LHbeta-subunit gene in Japanese patients with ovulatory disorders","volume":"11","author":"Takahashi","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.cca.2005.10.017_bib96","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0015-0282(97)00445-7","article-title":"A new molecular variant of luteinizing hormone associated with female infertility","volume":"69","author":"Liao","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cca.2005.10.017_bib97","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0015-0282(00)01616-2","article-title":"Association of AccI polymorphism in the follicle-stimulating hormone beta gene with polycystic ovary syndrome","volume":"74","author":"Tong","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cca.2005.10.017_bib98","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-2001-14941","article-title":"Absence of mutations in the coding regions of follicle-stimulating hormone receptor gene in Singapore Chinese women with premature ovarian failure and polycystic ovary syndrome","volume":"33","author":"Tong","year":"2001","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.cca.2005.10.017_bib99","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/me.13.6.946","article-title":"Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries","volume":"13","author":"Nelson","year":"1999","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.cca.2005.10.017_bib100","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1210\/jc.86.12.5925","article-title":"The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome","volume":"86","author":"Nelson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib101","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1210\/jc.85.6.2304","article-title":"Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells","volume":"85","author":"Wickenheisser","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib102","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1210\/jc.2004-1860","article-title":"Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome","volume":"90","author":"Wickenheisser","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib103","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/me.2004-0178","article-title":"Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome","volume":"19","author":"Nelson-Degrave","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.cca.2005.10.017_bib104","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1210\/me.2003-0090","article-title":"Increased cytochrome P450 17alpha-hydroxylase promoter function in theca cells isolated from patients with polycystic ovary syndrome involves nuclear factor-1","volume":"18","author":"Wickenheisser","year":"2004","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.cca.2005.10.017_bib105","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1210\/jc.2005-0330","article-title":"Retinoids and retinol differentially regulate steroid biosynthesis in ovarian theca cells isolated from normal cycling women and women with polycystic ovary syndrome","volume":"90","author":"Wickenheisser","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib106","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jri.2004.01.010","article-title":"The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling","volume":"63","author":"Wood","year":"2004","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.cca.2005.10.017_bib107","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1073\/pnas.92.23.10619","article-title":"Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome","volume":"92","author":"Zhang","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2005.10.017_bib108","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0303-7207(98)00177-4","article-title":"Role of cytochrome P450c17 in polycystic ovary syndrome","volume":"145","author":"Qin","year":"1998","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.cca.2005.10.017_bib109","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1210\/jc.85.11.4338","article-title":"Enzymatic activities of P450c17 stably expressed in fibroblasts from patients with the polycystic ovary syndrome","volume":"85","author":"Martens","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib110","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/hmg\/3.10.1873","article-title":"Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17","volume":"3","author":"Carey","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cca.2005.10.017_bib111","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0015-0282(98)00512-3","article-title":"Polymorphism T\u290dC (\u221234 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome","volume":"71","author":"Diamanti-Kandarakis","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cca.2005.10.017_bib112","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2265.1997.1450937.x","article-title":"The 17 alpha-hydroxylase\/17,20 lyase gene (CYP17) and polycystic ovary syndrome","volume":"46","author":"Franks","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cca.2005.10.017_bib113","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0950-351X(96)80057-7","article-title":"Hypersecretion of androgens by polycystic ovaries: the role of genetic factors in the regulation of cytochrome P450c17 alpha","volume":"10","author":"Franks","year":"1996","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib114","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF03346901","article-title":"CYP17 gene analysis in hyperandrogenised women with and without exaggerated 17-hydroxyprogesterone response to ovarian stimulation","volume":"20","author":"Liovic","year":"1997","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.cca.2005.10.017_bib115","first-page":"123","article-title":"Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5\u2032-UTR in patients with polycystic ovarian syndrome","volume":"15","author":"Marszalek","year":"2001","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.cca.2005.10.017_bib116","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2265.1997.8700880.x","article-title":"Frequency of a polymorphism in the regulatory region of the 17\u03b1-hydroxylase (CYP17) gene in hyperandrogenic states","volume":"46","author":"Techatraisk","year":"1997","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.cca.2005.10.017_bib117","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1083-3188(98)70132-9","article-title":"17 alpha-hydroxylase\/17,20-lyase dysregulation is not caused by mutations in the coding regions of CYP17","volume":"11","author":"Witchel","year":"1998","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.cca.2005.10.017_bib118","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/6.3.397","article-title":"Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism","volume":"6","author":"Gharani","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cca.2005.10.017_bib119","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0015-0282(99)00628-7","article-title":"Microsatellite polymorphism (tttta) at-528 base pairs of gene CYP11a influences hyperandrogenemia in patients with polycystic ovary syndrome","volume":"73","author":"Diamanti-Kandarakis","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cca.2005.10.017_bib120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0015-0282(01)02999-5","article-title":"Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17alpha-hydroxylase\/C(17\u201320) lyase promoters","volume":"77","author":"Daneshmand","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cca.2005.10.017_bib121","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0015-0282(01)01677-6","article-title":"Role of the pentanucleotide (tttta)n polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutism","volume":"75","author":"San Mill\u00e1n","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cca.2005.10.017_bib122","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1210\/jc.86.4.1746","article-title":"Screening for mutations in the steroidogenic acute regulatory protein and steroidogenic factor-1 genes, and in CYP11A and dosage-sensitive sex reversal-adrenal hypoplasia gene on the X chromosome, gene-1 (DAX-1), in hyperandrogenic hirsute women","volume":"86","author":"Calvo","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib123","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1056\/NEJM199009273231301","article-title":"ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism","volume":"323","author":"Siegel","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2005.10.017_bib124","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1056\/NEJM199009273231302","article-title":"Secondary biosynthetic defects in women with late-onset congenital adrenal hyperplasia","volume":"323","author":"Eldar Geva","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2005.10.017_bib125","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1203\/00006450-199506000-00024","article-title":"Absence of molecular defect in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3 beta-HSD activity","volume":"37","author":"Chang","year":"1995","journal-title":"Pediatr Res"},{"key":"10.1016\/j.cca.2005.10.017_bib126","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0015-0282(99)00317-9","article-title":"The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype\u2013genotype correlations","volume":"72","author":"Escobar-Morreale","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cca.2005.10.017_bib127","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1210\/jc.2003-030934","article-title":"The hormonal phenotype of nonclassic 3\u03b2-hydroxysteroid dehydrogenase (HSD3B) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not a variant of inherited HSD3B2 deficiency","volume":"89","author":"Carbunaru","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib128","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1210\/jc.83.8.2855","article-title":"Deleterious missense mutations and silent polymorphism in the human 17beta-hydroxysteroid dehydrogenase 3 gene (HSD17B3)","volume":"83","author":"Moghrabi","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib129","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/er.2003-0031","article-title":"11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response","volume":"25","author":"Tomlinson","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cca.2005.10.017_bib130","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ng1214","article-title":"Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency","volume":"34","author":"Draper","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.cca.2005.10.017_bib131","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1210\/jc.2004-1523","article-title":"A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11beta-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome","volume":"90","author":"San Millan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib132","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1210\/jc.2005-0942","article-title":"Genotypes at HSD11B1 and H6PD loci are not risk factors for apparent cortisone reductase deficiency in a large population-based sample","volume":"90","author":"White","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib133","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1172\/JCI0214060","article-title":"Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction","volume":"109","author":"Hogeveen","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2005.10.017_bib134","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1210\/jc.2003-030197","article-title":"Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels","volume":"88","author":"Xita","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib135","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1210\/jc.2002-021553","article-title":"Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women","volume":"89","author":"Cousin","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib136","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/molehr\/gah178","article-title":"Association of SHBG gene polymorphism with menarche","volume":"11","author":"Xita","year":"2005","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.cca.2005.10.017_bib137","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1210\/jc.84.7.2414","article-title":"5alpha-reductase activity in women with polycystic ovary syndrome","volume":"84","author":"Jakimiuk","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib138","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/edrv-11-2-201","article-title":"Steroid receptor family: structure and functions","volume":"11","author":"Carson-Jurica","year":"1990","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cca.2005.10.017_bib139","first-page":"701","article-title":"Size polymorphisms of the androgen receptor among female Hispanics and correlation with androgenic characteristics","volume":"83","author":"Legro","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cca.2005.10.017_bib140","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1210\/jc.2002-021791","article-title":"Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism","volume":"88","author":"Ibanez","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib141","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1210\/jc.84.3.1091","article-title":"Androgen receptor-mediated hypersensitivity to androgens in women with nonhyperandrogenic hirsutism: skewing of X-chromosome inactivation","volume":"84","author":"Vottero","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib142","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1210\/jc.87.1.161","article-title":"The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome","volume":"87","author":"Hickey","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib143","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1210\/jc.85.4.1735","article-title":"The role of the CAG repeat polymorphism in the androgen-receptor gene and of skewed X-chromosome inactivation, in the pathogenesis of hirsutism","volume":"85","author":"Calvo","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib144","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2005.10.017_bib145","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1161\/01.CIR.93.10.1809","article-title":"Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators","volume":"93","author":"Howard","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2005.10.017_bib146","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2005.10.017_bib147","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(01)06112-8","article-title":"Role of inflammatory biomarkers in prediction of coronary heart disease","volume":"358","author":"Ridker","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2005.10.017_bib148","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-2796.1999.00490.x","article-title":"The role of TNFalpha and TNF receptors in obesity and insulin resistance","volume":"245","author":"Hotamisligil","year":"1999","journal-title":"J Intern Med"},{"key":"10.1016\/j.cca.2005.10.017_bib149","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cca.2005.10.017_bib150","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2004-0628","article-title":"The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome","volume":"90","author":"Orio","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib151","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1093\/humrep\/dei072","article-title":"High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception","volume":"20","author":"Ibanez","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cca.2005.10.017_bib152","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1210\/jc.2003-031365","article-title":"Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity","volume":"89","author":"Escobar-Morreale","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib153","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000058367","article-title":"The plasma homocysteine levels are increased in polycystic ovary syndrome","volume":"53","author":"Loverro","year":"2002","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.cca.2005.10.017_bib154","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.2337\/diacare.28.8.2042","article-title":"Body iron stores are increased in overweight and obese women with polycystic ovary syndrome","volume":"28","author":"Escobar-Morreale","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2005.10.017_bib155","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1126\/science.271.5249.665","article-title":"IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance","volume":"271","author":"Hotamisligil","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.cca.2005.10.017_bib156","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1210\/endo-126-5-2711","article-title":"Effects of tumor necrosis factor-alpha in vitro on steroidogenesis of healthy and atretic follicles of the rat: theca as a target","volume":"126","author":"Roby","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2005.10.017_bib157","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1095\/biolreprod61.4.993","article-title":"Tumor necrosis factor-alpha stimulates proliferation of rat ovarian theca-interstitial cells","volume":"61","author":"Spaczynski","year":"1999","journal-title":"Biol Reprod"},{"key":"10.1016\/j.cca.2005.10.017_bib158","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1210\/en.137.11.4864","article-title":"Tumor necrosis factor-alpha and its second messenger, ceramide, stimulate apoptosis in cultured ovarian follicles","volume":"137","author":"Kaipia","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2005.10.017_bib159","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0026-0495(99)90100-2","article-title":"Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome","volume":"48","author":"Gonzalez","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2005.10.017_bib160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/molehr\/5.1.5","article-title":"No association between the\u2212308 polymorphism in the tumour necrosis factor alpha (TNFalpha) promoter region and polycystic ovaries","volume":"5","author":"Milner","year":"1999","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.cca.2005.10.017_bib161","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/713603095","article-title":"Lack of association between C-850T polymorphism of the gene encoding tumor necrosis factor-alpha and polycystic ovary syndrome","volume":"16","author":"Korhonen","year":"2002","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.cca.2005.10.017_bib162","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1210\/en.139.12.4832","article-title":"Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity","volume":"139","author":"Uysal","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2005.10.017_bib163","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJM199606273342607","article-title":"The tumor necrosis factor ligand and receptor families","volume":"334","author":"Bazzoni","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2005.10.017_bib164","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2337\/diabetes.47.11.1757","article-title":"Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance","volume":"47","author":"Fernandez-Real","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2005.10.017_bib165","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2337\/diabetes.48.5.1108","article-title":"Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy","volume":"48","author":"Fernandez-Real","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2005.10.017_bib166","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1210\/jc.85.3.1331","article-title":"Interleukin-6: the endocrine cytokine","volume":"85","author":"Papanicolaou","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib167","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/0264-6021:3610105","article-title":"Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation","volume":"361","author":"Haan","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.cca.2005.10.017_bib168","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.fertnstert.2004.01.021","article-title":"A common interleukin-6 gene promoter polymorphism influences the clinical characteristics of women with polycystic ovary syndrome","volume":"81","author":"Walch","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cca.2005.10.017_bib169","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/jc.87.8.3871","article-title":"Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state","volume":"87","author":"Yildiz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib170","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/humrep\/17.2.314","article-title":"Polycystic ovarian syndrome and thrombophilia","volume":"17","author":"Tsanadis","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cca.2005.10.017_bib171","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0015-0282(00)00630-0","article-title":"Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage","volume":"74","author":"Glueck","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cca.2005.10.017_bib172","doi-asserted-by":"crossref","first-page":"37J","DOI":"10.1016\/S0002-9149(99)00357-4","article-title":"Insulin resistance and thrombosis: a cardiologist's view","volume":"84","author":"Sobel","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cca.2005.10.017_bib173","doi-asserted-by":"crossref","first-page":"C1391","DOI":"10.1152\/ajpcell.1999.276.6.C1391","article-title":"TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes","volume":"276","author":"Sakamoto","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cca.2005.10.017_bib174","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0026-0495(97)90066-4","article-title":"Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome","volume":"46","author":"Velazquez","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2005.10.017_bib175","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0026-0495(99)90250-0","article-title":"Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome","volume":"48","author":"Glueck","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2005.10.017_bib176","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1210\/jc.82.7.2108","article-title":"Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2005.10.017_bib177","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1365-2265.2000.00946.x","article-title":"Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS)","volume":"52","author":"Atiomo","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cca.2005.10.017_bib178","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1007\/s001250050606","article-title":"Promoter (4G\/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome","volume":"39","author":"McCormack","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2005.10.017_bib179","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1530\/eje.0.1500793","article-title":"The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels","volume":"150","author":"Diamanti-Kandarakis","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cca.2005.10.017_bib180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejogrb.2005.07.002","article-title":"A polymorphism of the plasminogen activator inhibitor-1 gene promoter and the polycystic ovary syndrome","volume":"123","author":"Walch","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.cca.2005.10.017_bib181","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00060793-200212000-00006","article-title":"Gonadotropin secretory dynamics in polycystic ovary syndrome","volume":"9","author":"Baker","year":"2002","journal-title":"Curr Opin Endocrinol Diabetes"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898105006364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898105006364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T20:33:39Z","timestamp":1683318819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898105006364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":181,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0009898105006364"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2005.10.017","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}